These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31612183)

  • 1. Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours.
    Karlsson J; Rui Y; Kozielski KL; Placone AL; Choi O; Tzeng SY; Kim J; Keyes JJ; Bogorad MI; Gabrielson K; Guerrero-Cazares H; Quiñones-Hinojosa A; Searson PC; Green JJ
    Nanoscale; 2019 Nov; 11(42):20045-20057. PubMed ID: 31612183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.
    Liu Y; Zou Y; Feng C; Lee A; Yin J; Chung R; Park JB; Rizos H; Tao W; Zheng M; Farokhzad OC; Shi B
    Nano Lett; 2020 Mar; 20(3):1637-1646. PubMed ID: 32013452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a hybrid nanocarrier-recognizing tumor vasculature and penetrating the BBB for glioblastoma multi-targeting therapy.
    Fan R; Chuan D; Hou H; Chen H; Han B; Zhang X; Zhou L; Tong A; Xu J; Guo G
    Nanoscale; 2019 Jun; 11(23):11285-11304. PubMed ID: 31165845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
    Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
    Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood-brain barrier and glioma cells.
    Bruun J; Larsen TB; Jølck RI; Eliasen R; Holm R; Gjetting T; Andresen TL
    Int J Nanomedicine; 2015; 10():5995-6008. PubMed ID: 26451106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual functional nanoparticles efficiently across the blood-brain barrier to combat glioblastoma
    Jin Z; Piao L; Sun G; Lv C; Jing Y; Jin R
    J Drug Target; 2021 Mar; 29(3):323-335. PubMed ID: 33108906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy.
    Yang ZZ; Gao W; Liu YJ; Pang N; Qi XR
    Mol Pharm; 2017 Apr; 14(4):1012-1022. PubMed ID: 28252970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy.
    Gregory JV; Kadiyala P; Doherty R; Cadena M; Habeel S; Ruoslahti E; Lowenstein PR; Castro MG; Lahann J
    Nat Commun; 2020 Nov; 11(1):5687. PubMed ID: 33173024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
    Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
    Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailored polymer-lipid hybrid nanoparticles for the delivery of drug conjugate: dual strategy for brain targeting.
    Agrawal U; Chashoo G; Sharma PR; Kumar A; Saxena AK; Vyas SP
    Colloids Surf B Biointerfaces; 2015 Feb; 126():414-25. PubMed ID: 25601092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.
    Wang L; Hao Y; Li H; Zhao Y; Meng D; Li D; Shi J; Zhang H; Zhang Z; Zhang Y
    J Drug Target; 2015; 23(9):832-46. PubMed ID: 25856302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin α
    Huang CW; Chuang CP; Chen YJ; Wang HY; Lin JJ; Huang CY; Wei KC; Huang FT
    J Nanobiotechnology; 2021 Jun; 19(1):180. PubMed ID: 34120610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2.
    Kou L; Hou Y; Yao Q; Guo W; Wang G; Wang M; Fu Q; He Z; Ganapathy V; Sun J
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1605-1616. PubMed ID: 28974108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetrating the Blood-Brain Barrier by Self-Assembled 3D DNA Nanocages as Drug Delivery Vehicles for Brain Cancer Therapy.
    Tam DY; Ho JW; Chan MS; Lau CH; Chang TJH; Leung HM; Liu LS; Wang F; Chan LLH; Tin C; Lo PK
    ACS Appl Mater Interfaces; 2020 Jul; 12(26):28928-28940. PubMed ID: 32432847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioreducible cationic polymer-based nanoparticles for efficient and environmentally triggered cytoplasmic siRNA delivery to primary human brain cancer cells.
    Kozielski KL; Tzeng SY; De Mendoza BA; Green JJ
    ACS Nano; 2014 Apr; 8(4):3232-41. PubMed ID: 24673565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
    Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
    J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-sensitizing nanoparticle complex for overcoming the blood-brain barrier: an effective drug delivery system.
    Ha SW; Hwang K; Jin J; Cho AS; Kim TY; Hwang SI; Lee HJ; Kim CY
    Int J Nanomedicine; 2019; 14():3743-3752. PubMed ID: 31213800
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigation on the effect of nanoparticle size on the blood-brain tumour barrier permeability by in situ perfusion via internal carotid artery in mice.
    Kang JH; Cho J; Ko YT
    J Drug Target; 2019 Jan; 27(1):103-110. PubMed ID: 29972326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Effect of Cabazitaxel and Blood-Brain Barrier opening in a Patient-Derived Glioblastoma Model.
    Sulheim E; Mørch Y; Snipstad S; Borgos SE; Miletic H; Bjerkvig R; Davies CL; Åslund AKO
    Nanotheranostics; 2019; 3(1):103-112. PubMed ID: 30899638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.